LRVHealth — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)Louis Samson(Director)
Board seatWord D. Peake III· per SEC Form D
Co-investorsBattery VenturesBreyer CapitalInsight PartnersNew Leaf Venture PartnersVensana Capital
Humata provides an end-to-end platform to streamline prior authorization processes in healthcare, reducing delays and improving care access for patients.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMiami, US
Jeremy Friese(Founder, MD)inOscar Callejas(Executive Officer)inMichael Kolb(Executive Officer)inWord D. Peake(Director)Thomas Hawes(Director)Philip Fibiger(Executive Officer)in
Board seatWord D. Peake· per SEC Form D
Co-investors.406 VenturesBlue Venture FundsOptum VenturesOSF Ventures
Sware offers the GxP Suite, a SaaS validation platform (Res_Q) that uses AI agents to manage software, plant/equipment, and medical device validation while maintaining audit readiness.
AI & Machine LearningHealthtechSaaSChelsea, US
Bryan Ennis(Co-Founder & Chief Quality Officer)inELLEN REILLY(Executive Officer, Director)BRYAN ENNIS(Executive Officer, Director)Ellen Reilly(Chief Executive Officer)inTheresa Pauzer(Chief People Officer)inEvan Raggi(Chief Commercial Officer)in
Board seatWilliam R. Cowen· per SEC Form D
Co-investorsFirst AnalysisInsight PartnersJumpstart CapitalNew Stack Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.